LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2025 MaTOS Breast 2025 MaTOS GU 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Clear Displaying 751 - 775 of 2,995 « 1 … 29 30 31 32 33 … 120 » Minimally Invasive Pancreatic Resection, Who Benefits? By: Melissa E. Hogg, MD Esophageal Carcinoma – Finally Something Practice Changing By: Midhun Malla, MD, MS Developments in Gastric, and Esophageal Tumors By: Mike Cusnir, MD View PDF Developments in Gastric, and Esophageal Tumors By: Mike Cusnir, MD View Video Esophageal, Gastric and GE Junction Tumors: What’s New in 2023? By: Mike Cusnir, MD View PDF Esophageal, Gastric and GE Junction Tumors: What’s New in 2023? By: Mike Cusnir, MD View Video How Precision Medicine is Changing Gastric and Esophageal Cancer Management By: Mike Cusnir, MD View PDF Cholangiocarcinoma, Hepatoma and Pancreas: What’s New By: Mike Cusnir, MD View PDF Esophageal and Gastric Carcinomas: Moving the Bar Up after ESMO 2024 By: Mike Cusnir, MD View PDF Esophageal and Gastric Carcinomas: Moving the Bar Up after ESMO 2024 By: Mike Cusnir, MD View Video Risk Factors for Pancreatic Cancer, Why is the Incidence Increasing? By: Mike Cusnir, MD Treatment of Metastatic Pancreatic Cancer---What Direction are We Going? By: Mike Cusnir, MD Targeted Therapies in Bile Duct Cancer By: Mike Cusnir, MD Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2024 By: Mitesh Borad, MD View PDF Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2024 By: Mitesh Borad, MD View Video HCC and Pancreatic Cancer: Novel Therapies after ASCO and ESMO 2024 By: Mitesh Borad, MD View PDF HCC and Pancreatic Cancer: Novel Therapies after ASCO and ESMO 2024 By: Mitesh Borad, MD View Video ctDNA in Adjuvant and Metastatic Therapy for GI Cancers: Prime Time? By: Olatunji B. Alese, MD, FWACS View PDF ctDNA in Adjuvant and Metastatic Therapy for GI Cancers: Prime Time? By: Olatunji B. Alese, MD, FWACS View Video Optimal Therapeutic Strategies in GI Cancers By: Panel View Video Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers By: Pashtoon Kasi, MD, MS View PDF Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers By: Pashtoon Kasi, MD, MS View Video Novel Immunotherapy Approaches in Hepatobiliary Malignancies By: Rachna T. Shroff, MD, MS View PDF Novel Immunotherapy Approaches in Hepatobiliary Malignancies By: Rachna T. Shroff, MD, MS View Video Updates in Gastrointestinal Cancers By: Richard Bold, MD, MBA View PDF ← Previous ViewNext View → We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
